-
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings
03 Feb 2026 15:42 GMT
… transplantation (HCT) in patients with hematologic malignancies. AlloHeme identifies cancer relapse …
-
Hematology Oncology of Indiana and American Oncology Network Welcome Dr. Amy Braden
03 Feb 2026 13:00 GMT
… and YouTube. About Hematology Oncology of Indiana Hematology Oncology of Indiana is … community-based medical oncology and hematology practice providing treatment for patients … healthcare journey. Learn more at hematologyoncology.com. A photo accompanying this …
-
<![CDATA[How to Responsibly Use AI in Palliative Care and Hematologic Malignancies]]>
02 Feb 2026 18:12 GMT
… and the management of different hematologic malignancies. He spoke in the … Palliative Oncology: Zeroing in on Hematologic Malignancies,which was featured in …
-
Most Innovative Meetings 2025: Nashville Hematology Conference
02 Feb 2026 13:27 GMT
… gap for community oncologists and hematologists seeking timely, relevant education … chair. “Between community oncologists, hematologists, and other specialists, the … integrated approach, spanning multiple hematologic malignancies within each session …
-
The Minister of Health criticized the head of the National Center for Oncology and Hematology
01 Feb 2026 00:46 GMT
At the meeting dedicated to the results of the healthcare system's work for 2025, the minister emphasized the existing problems of the oncology service in the country.
He noted that the high mortality rate from oncological diseases is due to a lack of …
-
<![CDATA[Is Rare Disease Policy a Stress Test of US Health Care?]]>
04 Feb 2026 04:03 GMT
… each year, along with neurology, hematology, and gastroenterology/liver.2 … at least 1 approval. Rare hematologic cancers benefited the most as …
-
Chasing cost: Cancer care toxicity and the hope from Biosimilars
04 Feb 2026 04:15 GMT
… was recounted by the eminent hematologist during a virtual lecture for …
-
Medexus Schedules Third Fiscal Quarter 2026 Conference Call
04 Feb 2026 00:57 GMT
… on the therapeutic areas of hematology and hematology-oncology and rheumatology and …
-
Rallybio Announces Reverse Stock Split of Common Stock
04 Feb 2026 00:57 GMT
… areas of complement dysregulation and hematology. The Company's lead …
-
<![CDATA[Dato-DXd Earns Priority Review in Unresectable/Metastatic TNBC]]>
04 Feb 2026 00:24 GMT
… Galbraith, executive vice president, Oncology Hematology Research and Development, AstraZeneca, said …